Here is the complete, detailed account of General Anaesthesia drawn from all the major textbooks.
General Anaesthesia - Complete & Detailed
Sources: Miller's Anesthesia 10e | Morgan & Mikhail's Clinical Anesthesiology 7e | Barash Clinical Anesthesia 9e | Bailey & Love's Surgery 28e | Lippincott Illustrated Reviews: Pharmacology
1. DEFINITION
General anaesthesia is a reversible state of central nervous system (CNS) depression causing:
- Loss of response to stimuli
- Loss of perception of stimuli
- Loss of consciousness (unarousable)
"General anaesthesia is commonly described as the triad of unconsciousness, analgesia, and muscle relaxation." - Bailey & Love's Surgery, 28e
This triad is also described as:
- Amnesia - loss of awareness/memory
- Analgesia - pain relief
- Muscle relaxation - for surgical access and ventilation
2. INDICATIONS FOR GENERAL ANAESTHESIA
GA is chosen when:
- Surgery is of long duration
- Surgery involves body cavities (abdomen, thorax, skull) requiring full muscle relaxation
- Patient refuses regional anaesthesia
- Regional technique is contraindicated (coagulopathy, infection at injection site, increased ICP)
- Pediatric patients who cannot cooperate for awake/regional procedures
- Emergency surgery with full stomach (RSI)
- Surgery requires specific patient positioning (prone, lateral, sitting) incompatible with regional
- Anticipated difficult airway requiring controlled management under GA
- Complex, unstable, multi-organ procedures
3. PREOPERATIVE PREPARATION FOR GA
Before any GA, a structured pre-anaesthetic evaluation and preparation is required.
A. Preoperative Assessment
- History and physical examination
- ASA physical status classification (I-VI)
- Assessment of:
- Airway (Mallampati score, mouth opening, neck mobility, thyromental distance)
- Cardiovascular and respiratory status
- Medications, allergies, previous anaesthetic history
- Family history of anaesthetic problems (malignant hyperthermia)
B. Airway Assessment (Mallampati Classification)
| Class | Visible Structures | Risk |
|---|
| I | Soft palate, fauces, uvula, pillars | Easy intubation |
| II | Soft palate, fauces, uvula (partially) | - |
| III | Soft palate, base of uvula only | Difficult |
| IV | Soft palate not visible | Very difficult |
C. Preoperative Fasting (NPO Guidelines)
Fasting before GA is mandatory to reduce the risk of pulmonary aspiration of gastric contents during induction. - Morgan & Mikhail, 7e
| Intake | Minimum Fasting Period |
|---|
| Clear fluids (water, clear juice, tea) | 2 hours |
| Breast milk | 4 hours |
| Formula / light meal | 6 hours |
| Full meal (meat, fried foods) | 8 hours |
There is no evidence that prolonged fasting beyond these guidelines decreases aspiration risk. In fact, some studies show longer fasting may increase gastric acidity and residual volume.
D. Premedication
Goals: reduce anxiety, provide analgesia, reduce secretions, prevent aspiration, and facilitate smooth induction.
| Drug Class | Example | Effect |
|---|
| Benzodiazepines | Midazolam 0.3-0.5 mg/kg oral; 0.02-0.05 mg/kg IV | Anxiolysis, amnesia, sedation |
| Opioids | Morphine, fentanyl | Pre-emptive analgesia |
| Anticholinergics | Atropine, glycopyrrolate | Reduce secretions, prevent bradycardia |
| Antacids / H2 blockers | Ranitidine, omeprazole | Raise gastric pH - reduce aspiration injury |
| Antiemetics | Ondansetron | Prophylactic PONV prevention |
4. THE THREE STAGES OF GENERAL ANAESTHESIA
"General anesthesia can be divided into three stages: induction, maintenance, and emergence." - Lippincott Illustrated Reviews: Pharmacology
INDUCTION → MAINTENANCE → EMERGENCE
(Awake → Unconscious) (Sustained GA) (Unconscious → Awake)
STAGE 1: INDUCTION
Definition: The period from administration of the anaesthetic agent to the development of unconsciousness and readiness for airway management.
Routes of Induction
A. Intravenous (IV) Induction - Most Common in Adults
Standard sequence:
- Pre-oxygenate with 100% O₂ for 3-5 minutes (fills FRC with O₂ - creates "oxygen reservoir")
- Administer IV induction agent (propofol most common)
- Assess loss of consciousness (loss of eyelash reflex, verbal contact)
- Administer neuromuscular blocking agent (NMB)
- Mask ventilate until intubation conditions optimal
- Perform laryngoscopy and endotracheal intubation or insert LMA
- Confirm tube placement (bilateral chest rise, capnography, misting)
- Connect to anaesthetic circuit; begin maintenance
| Agent | Dose | Onset | Key Feature |
|---|
| Propofol | 1.5-2.5 mg/kg | 30-60 sec | Gold standard; lowest PONV; antiemetic |
| Thiopentone | 3-5 mg/kg | 15-30 sec | Classic barbiturate; reduces ICP |
| Etomidate | 0.2-0.3 mg/kg | 30-60 sec | Hemodynamically stable; myoclonus |
| Ketamine | 1-2 mg/kg | 30-60 sec | Dissociative; analgesic; bronchodilator |
| Midazolam | 0.1-0.3 mg/kg | 2-3 min | Amnesia + anxiolysis; adjunct |
B. Inhalational Induction - Children, Difficult Airway
- Agent: Sevoflurane (non-pungent, fast onset - blood-gas coefficient 0.65)
- Used in children (no IV access), needle-phobic adults, anticipated difficult airway
- Patient breathes increasing concentrations via facemask
- "Steal induction" in children sedated with oral midazolam - placed on table asleep
- Maintains spontaneous breathing until airway is secured
Rapid Sequence Induction (RSI)
Used when aspiration risk is high - full stomach, emergency surgery, bowel obstruction, pregnancy, GERD, morbid obesity, diabetic gastroparesis. - Miller's Anesthesia 10e
RSI Steps (STOMP):
- Set up: IV access, monitoring, drugs drawn up, suction, difficult airway equipment ready
- Tilt: 20° head-up (ramp position) reduces aspiration risk
- Oxygenate: pre-oxygenate with 100% O₂ for 3 minutes
- Medicate: predetermined IV induction dose (propofol, etomidate, or ketamine) followed immediately by succinylcholine 1-1.5 mg/kg (or rocuronium 1.2 mg/kg)
- Pressure: apply cricoid pressure (Sellick maneuver) at 10 N (awake) → 30 N after loss of consciousness
Cricoid pressure (Sellick maneuver):
- Pressure applied at the cricoid cartilage to compress and occlude the upper oesophagus against the cervical vertebra
- Prevents regurgitation of gastric contents into the pharynx during the unprotected period
- Controversial: MRI studies show it may laterally displace (not compress) the oesophagus; can worsen laryngoscopic view; but widely practiced
- No bag-mask ventilation between induction and intubation (minimises gastric insufflation)
- Airway secured with cuffed ETT before cricoid pressure released
When succinylcholine is contraindicated (burns >24h, crush injuries, hyperkalemia, personal/family history of malignant hyperthermia): use rocuronium 1.2 mg/kg - reversal available with sugammadex 16 mg/kg
5. AIRWAY MANAGEMENT DURING GA
A. Facemask Ventilation
- Used during induction before definitive airway secured
- Adjuncts: oropharyngeal (Guedel) airway, nasopharyngeal airway
- Guedel airway: holds tongue forward, prevents airway obstruction, but does NOT protect against aspiration
B. Supraglottic Airways (SGAs)
| Device | Description |
|---|
| LMA (Laryngeal Mask Airway) | Sits above glottis with inflatable cuff; no intubation required; less invasive than ETT |
| LMA ProSeal / i-gel (2nd gen) | Higher pressures, oesophageal drain port; better seal; safer for obese patients |
| ILMA (Intubating LMA) | Allows blind ETT insertion through the LMA |
LMA is NOT suitable for: full stomach patients, patients needing high airway pressures, prone position surgeries, or thoracic surgery.
C. Endotracheal Intubation (ETT) - Gold Standard
- Provides fully secured, protected airway
- Cuffed tube prevents aspiration
- Allows controlled positive-pressure ventilation (PPV)
Complications of intubation: - Bailey & Love 28e
- Failed intubation
- Accidental bronchial intubation (right main bronchus most commonly)
- Trauma to teeth, pharynx, or larynx
- Aspiration of gastric contents during intubation
- Tube disconnection, blockage, or kinking
- Delayed tracheal stenosis
D. Difficult Airway
Anticipated difficult airway managed with:
- Video laryngoscope (McGrath, C-MAC, Airtraq) - provides improved view
- Fibreoptic intubating bronchoscope - awake fibreoptic intubation with topical local anaesthetic; patient maintains own airway until tube secured; gold standard for known difficult airway - Bailey & Love 28e
- Surgical airway (cricothyrotomy, tracheostomy) - last resort
STAGE 2: MAINTENANCE
Definition: The sustained period of GA from intubation/LMA insertion until the end of surgery, keeping the patient safely unconscious, pain-free, and still. - Lippincott Pharmacology
Methods of Maintenance
A. Inhalational Maintenance
Most common. Volatile agent + O₂ ± N₂O delivered via the anaesthetic machine and breathing circuit.
Key volatile agents:
| Agent | Blood-Gas Coeff. | MAC | Induction? | Key Features |
|---|
| Sevoflurane | 0.65 | 2.0% | Yes | Most popular; fast on/off; bronchodilator |
| Isoflurane | 1.4 | 1.15% | No (pungent) | Standard maintenance; peripheral vasodilation; tachycardia |
| Desflurane | 0.42 | 6.0% | No (pungent) | Fastest recovery; contraindicated for induction; irritates airway |
| Halothane | 2.4 | 0.75% | Historically | Now largely obsolete; hepatotoxicity, arrhythmias |
MAC (Minimum Alveolar Concentration): The alveolar concentration of an inhalational agent at 1 atmosphere that prevents movement in response to a surgical incision in 50% of subjects. It is the measure of inhalational agent potency.
Factors that reduce MAC (deeper for same concentration):
- Increasing age
- Opioids, benzodiazepines, N₂O (all reduce required MAC)
- Hypothermia
- Hypotension, anaemia
- Pregnancy
Factors that increase MAC:
- Young age
- Hyperthermia
- Chronic alcohol use
- Stimulant drugs
Nitrous Oxide (N₂O) as adjunct:
- Low potency (MAC 104%) - cannot produce GA alone
- Analgesic and MAC-sparing (reduces volatile agent needed)
- Speeds inhalational induction
- Rapid elimination (fastest recovery)
- Avoid in: closed air-containing spaces (middle ear, pneumothorax, bowel obstruction, eye with gas tamponade, pneumocephalus)
- Associated with PONV
B. Total Intravenous Anaesthesia (TIVA)
- Propofol infusion (100-300 mcg/kg/min) + opioid infusion (remifentanil/fentanyl)
- No inhaled agents used
- Advantages: lowest PONV, avoids MH triggers, suitable for airway procedures, staff not exposed to waste gases
- BIS (Bispectral Index) monitoring guides depth - target BIS 40-60 for adequate GA
C. Balanced Anaesthesia
Combines drugs synergistically:
| Component | Drug(s) |
|---|
| Hypnosis/Amnesia | Volatile agent OR propofol infusion |
| Analgesia | Fentanyl, morphine, remifentanil, epidural |
| Muscle relaxation | NMBAs (rocuronium, vecuronium, atracurium) |
| Autonomic control | Beta-blockers, vasopressors, antihypertensives |
Muscle Relaxants During Maintenance
| Drug | Type | Duration | Notes |
|---|
| Succinylcholine | Depolarising | 8-10 min | RSI; fastest onset; contraindicated in burns, hyperkalemia, MH history |
| Rocuronium | Non-depolarising | 30-60 min | Rapid onset; reversible with sugammadex |
| Vecuronium | Non-depolarising | 30-60 min | Minimal CV effects; hepatic metabolism |
| Atracurium/Cisatracurium | Non-depolarising | 30-45 min | Hofmann degradation - safe in renal/hepatic failure |
| Pancuronium | Non-depolarising | 60-90 min | Long acting; vagolytic (tachycardia) |
Reversal of NMBAs:
- Neostigmine (0.04-0.07 mg/kg) + glycopyrrolate/atropine (to prevent bradycardia from neostigmine) - anticholinesterase; partially reverses non-depolarising NMBAs
- Sugammadex (2-16 mg/kg depending on depth of block) - encapsulates rocuronium/vecuronium; rapid, complete reversal even at deep block; preferred modern agent
- Peripheral nerve stimulator (TOF - Train of Four) monitoring confirms adequate reversal before extubation
6. INTRAOPERATIVE MONITORING DURING GA
"Monitoring requirements during GA ensure patient safety by detecting physiological derangements before they cause harm." - Miller's Anesthesia 10e
ASA Standard Monitors (Mandatory for every GA)
| Monitor | What It Measures | Why Important |
|---|
| Pulse oximetry (SpO₂) | Arterial O₂ saturation | Detects hypoxia immediately |
| Capnography (EtCO₂) | End-tidal CO₂ | Confirms intubation; monitors ventilation; detects air embolism, MH |
| ECG (3- or 5-lead) | Heart rate and rhythm | Detects arrhythmias, ischemia |
| Non-invasive BP (NIBP) | Blood pressure (every 5 min min) | Detects hypo/hypertension |
| Temperature | Core temperature | Detects hypothermia, MH |
| Inspired O₂ concentration | FiO₂ | Prevents hypoxic gas mixture delivery |
| Airway pressure / ventilator alarms | Peak/plateau pressure, tidal volume | Detects circuit disconnect, bronchospasm, tube obstruction |
Additional / Invasive Monitors (Selected Cases)
| Monitor | Use |
|---|
| Arterial line (IBP) | Beat-to-beat BP; cardiac surgery, major vascular, hemodynamically unstable |
| Central venous catheter (CVP) | Volume status, vasoactive drug administration; cardiac, major surgery |
| BIS (Bispectral Index) | Depth of anaesthesia; target 40-60 for GA; reduces awareness and drug overdose |
| Peripheral nerve stimulator (TOF) | Depth of neuromuscular block; confirms reversal before extubation |
| Pulmonary artery catheter | Cardiac output, PCWP; complex cardiac cases |
| Transoesophageal echocardiography (TOE/TEE) | Cardiac function, fluid assessment; cardiac surgery |
| Urinary catheter | Urine output (target >0.5 mL/kg/hr) |
| Nasopharyngeal / oesophageal temp probe | Core temperature |
STAGE 3: EMERGENCE
Definition: Begins with cessation of the maintenance anaesthetic and continues until the patient regains consciousness, protective reflexes, and the ability to maintain their own airway. - Morgan & Mikhail 7e
Steps in Emergence
- Reduce/stop anaesthetic agents - turn off volatile or propofol infusion
- Increase ventilation - helps eliminate volatile agents faster (emergence speed directly proportional to alveolar ventilation)
- Reverse NMBAs - neostigmine + glycopyrrolate, or sugammadex
- Ensure adequate analgesia - to prevent pain-induced tachycardia/hypertension on waking
- Suction pharynx of secretions, blood
- Wait for return of: spontaneous breathing, response to commands, ability to open eyes and mouth, adequate head lift (>5 seconds), cough reflex, swallowing
- Extubate - remove ETT when patient is awake, breathing adequately, and protective reflexes have returned
Criteria for Safe Extubation
- SpO₂ > 95% on FiO₂ ≤ 0.4
- Adequate spontaneous respiratory rate and tidal volume
- TOF ratio ≥ 0.9 (confirming NMB reversal)
- Patient responds to verbal commands
- Able to sustain head lift for 5 seconds
- Cough reflex present
- Temperature ≥ 36°C
Pharmacokinetics of Emergence
| Agent | Mechanism of offset | Speed |
|---|
| Propofol | Redistribution (initially) then metabolism | Fast |
| Remifentanil | Ester hydrolysis (ultra-short) | Fastest |
| Volatile agents | Exhalation (inversely proportional to blood-gas coefficient) | Desflurane > Sevoflurane > Isoflurane |
| Thiopentone | Redistribution (prolonged if high cumulative dose) | Slow with repeat dosing |
Context-sensitive half-time: As total anaesthetic dose increases, recovery becomes increasingly dependent on metabolism and elimination rather than just redistribution - relevant to prolonged infusions of propofol or remifentanil.
Complications of Emergence
| Complication | Cause | Management |
|---|
| Airway obstruction | Residual NMB, secretions, soft tissue collapse | Jaw thrust, suction, reintubate |
| Laryngospasm | Stimulation of vocal cords at light planes | Positive pressure, succinylcholine 0.1 mg/kg |
| Shivering | Hypothermia | Warming blankets; pethidine 25 mg IV |
| Emergence agitation/delirium | Especially with ketamine, children, elderly | Midazolam, propofol bolus |
| Pain | Inadequate analgesia | IV opioids, NSAIDs |
| PONV | Opioids, volatile agents, N₂O, female sex, motion sickness history | Ondansetron, dexamethasone, metoclopramide |
| Hypertension/tachycardia | Pain, hypoventilation, full bladder, emergence excitement | Treat cause; labetalol, esmolol |
| Hypotension | Hypovolaemia, residual agents, sepsis | IV fluids, vasopressors |
| Hypothermia | Heat loss in OR (redistribution, radiation, convection) | Forced-air warming; warmed IV fluids |
Delayed Emergence
Failure to regain consciousness within the expected timeframe. Causes:
- Most common - Residual drug effect (opioids, benzodiazepines, volatile agents)
- Reversal: Naloxone (80 mcg IV increments) for opioids; Flumazenil (0.2 mg increments) for benzodiazepines
- Hypothermia - core temp <33°C has anaesthetic effect
- Hypoglycaemia - check blood glucose immediately
- Metabolic disturbances - hyponatraemia, hypercalcaemia, hypermagnesaemia
- Perioperative stroke - rare; post-cardiac/neurovascular surgery
- Hypoxia or hypercarbia - check SpO₂ and arterial blood gas
7. POST-ANAESTHESIA CARE UNIT (PACU)
After surgery, the patient is transported to the PACU (Recovery Room) where:
- Oxygen supplementation is given
- Vital signs monitored every 5 minutes (SpO₂, BP, HR, RR, temperature)
- Pain assessed and managed (NRS/VAS score)
- PONV treated
- Discharge criteria (Aldrete score ≥ 9):
- Activity (able to move 4 extremities)
- Respiration (breathes deeply, coughs freely)
- Circulation (BP ±20% of pre-op)
- Consciousness (fully awake)
- Colour (normal/SpO₂ >92%)
8. SUMMARY FLOWCHART OF GENERAL ANAESTHESIA
PRE-OPERATIVE
───────────────────────────────────────────────────────
Assessment → Consent → Fasting (6h food, 2h fluids)
→ ASA classification → Premedication → IV access
INDUCTION
───────────────────────────────────────────────────────
Pre-oxygenation (3-5 min, 100% O₂)
↓
IV Agent (Propofol 1.5-2.5 mg/kg) OR Inhalational (Sevoflurane)
↓
Loss of consciousness
↓
NMB (Succinylcholine/Rocuronium) → Intubation / LMA
↓
Confirm placement (EtCO₂, chest rise, SpO₂)
MAINTENANCE
───────────────────────────────────────────────────────
Volatile agent (Sevoflurane/Isoflurane/Desflurane) ± N₂O
OR TIVA (Propofol infusion + Remifentanil)
+
Opioid analgesia (fentanyl/morphine)
+
NMB top-ups as needed
MONITOR: SpO₂, EtCO₂, ECG, BP, BIS, TOF, Temp
EMERGENCE
───────────────────────────────────────────────────────
Stop anaesthetic agents → Increase ventilation
→ Reverse NMBs (Neostigmine or Sugammadex)
→ Adequate spontaneous breathing
→ Awake, responsive, head lift 5 sec, TOF ≥ 0.9
→ Extubate safely
→ PACU monitoring and discharge criteria
Sources: Morgan and Mikhail's Clinical Anesthesiology, 7e - Chs. 1, 42 | Miller's Anesthesia, 2-Volume Set, 10e - Chs. 16, 21, 22 | Barash, Cullen & Stoelting's Clinical Anesthesia, 9e - Chs. 14, 15 | Bailey and Love's Short Practice of Surgery, 28e - Ch. 23 | Lippincott Illustrated Reviews: Pharmacology - Ch. 20